Translating Pre-Clinical Research to Clinical Patient Care™

JMSACL Logo
Educational Grant Partners: Why no logos? CME.
SCIEX

David Herold | Brian Kelly


Description

MSACL 2026
16th Annual Conference & Exhibits

Bonaventure Hotel Conference Center

Montréal, CANADA

October 4 - 9, 2026

Mission

MSACL's mission is to support the community in translating pre-clinical research to clinical patient care.

Conference Focus

MSACL is focused on providing a forum of interaction for participants in all stages of the development, advancement and use of analytical tools, including data analytics, in the clinic to improve patient care. Although the group primarily focuses on mass spectrometry, presentations and discussion on other platforms are welcome.

Location Overview

The Bonaventure Hotel is located in the heart of downtown Montréal on the 10th floor of Place Bonaventure building. The hotel has 397 guest rooms, their own internal meeting space (just a short escalator ride down from the hotel lobby), two restaurants and a bar. The hotel also features lush gardens, a rooftop outdoor heated pool (open year round), and offers panoramic views of the city, making it a distinctive and iconic location in Montréal.

We will be using the Bonaventure's St-Laurent room as the MSACL Exhibit Hall (20,140 square feet). There will be space for at 41 booths interspersed with up to 252 posters.

The Scientific Sessions will be held in the Salle de Balle de Montréal (Montréal Ballroom).

There were 628 attendees for MSACL 2025. We are expecting 600-700 for MSACL 2026.

Educational Grants

MSACL invests heavily in education via the MSACL Educational Grants, which support conference attendance:

  1. Young Investigator Grants: Young investigators, in the first four years of their academic position, who submit an abstract which is accepted for presentation (poster/podium) at the annual conference. Applicants must submit a short application.
  2. Lab Director Grants: Lab Directors interested in learning more about what mass spectrometry is and how it could potentially improve results and reduce costs in their clinical laboratory are not required to submit an abstract, but must submit a short application.
  3. Trainee Grants: Lab Directors-to-be interested in learning more about what mass spectrometry is and how it could potentially improve results and reduce costs in their clinical laboratory are not required to submit an abstract, but must submit a short application.

Scientific Program

A list of the topics being solicited for the current conference is below.

Abstract Submission Categories for MSACL 2026

  1. Artificial Intelligence
  2. Assays Leveraging Technology
  3. Breath Analysis and VOC
  4. Cases in Clinical Analysis
  5. Cases of Unmet Clinical Needs
  6. Data Analytics
  7. Emerging Technologies
  8. Environmental Sustainability
  9. Glycomics
  10. Identifying High Value Tests
  11. Informatics
  12. Lipidomics
  13. Metabolomics
  14. Microbiology
  15. Multi-omics
  16. Pre-Analytics
  17. Precision Medicine
  18. Proteomics
  19. Spatialomics
  20. Tox / TDM / Endocrine
  21. Troubleshooting
  22. Various OTHER

Target Audience

The target audience for this program includes pathologists, clinical laboratory directors and scientists, mass spectrometry and automated sample processing users and providers, as well as laboratory diagnostic providers.

This program will be beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.

Needs Assessment

With the advancement of technologies for clinical analysis, there exists a gap between those who understand the technology and those who do not. Without continual education, this gap will grow and these advancements are unlikely to be effectively incorporated into the clinical analysis workflow, resulting in lost opportunities to improve patient outcomes and reduce healthcare costs.

MSACL provides an environment through which participants will be able to identify opportunities to develop the capacity to provide higher quality results, more rapidly and for lower overall cost, for patients within the healthcare system.

This page loaded in: 1.474994 seconds